Hagen Brett R
SEC insider (Form 3/4/5 filer). CIK 0001681782. Chief Accounting Officer at Kalaris Therapeutics, Inc. (KLRS). 13 reported Form 4/5 transactions since Sep 2024; latest on Mar 20, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies Hagen Brett R has filed insider reports for
- Kalaris Therapeutics, Inc. (KLRS): Officer, Chief Accounting Officer
Hagen Brett R
CIK: 0001681782
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kalaris Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Mar 20, 2026KLRS
Kalaris Therapeutics, Inc.
SaleDirect1.9K shares at avg. $6.72$13K - Mar 19, 2026KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
60.8K shares- - Apr 10, 2025KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
50.3K shares- - Mar 26, 2025KLRS
Kalaris Therapeutics, Inc.
SaleDirect907 shares at avg. $8.97$8K - Feb 21, 2025ALVR
Allovir, Inc.
SaleDirect96 shares at avg. $10.08$967.277 - Jan 23, 2025ALVR
Allovir, Inc.
SaleDirect32 shares at avg. $9.45$302.522 - Jan 23, 2025ALVR
Allovir, Inc.
SaleDirect4 shares at avg. $9.94$39.761 - Jan 10, 2025ALVR
Allovir, Inc.
SaleDirect332 shares at avg. $0.44$146.113 - Nov 19, 2024ALVR
Allovir, Inc.
SaleDirect554 shares at avg. $0.55$303.869 - Nov 5, 2024ALVR
Allovir, Inc.
SaleDirect1.7K shares at avg. $0.86$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 20, 2026 | KLRS Kalaris Therapeutics, Inc. | Sale | 1,915 | $6.72 | $12,869 | Direct |
| Mar 19, 2026 | KLRS Kalaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 60,800 | - | - | Direct |
| Apr 10, 2025 | KLRS Kalaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 50,262 | - | - | Direct |
| Mar 26, 2025 | KLRS Kalaris Therapeutics, Inc. | Sale | 907 | $8.97 | $8,135 | Direct |
| Feb 21, 2025 |  ALVR Allovir, Inc. | Sale | 96 | $10.08 | $967 | Direct |
| Jan 23, 2025 | ALVR Allovir, Inc. | Sale | 32 | $9.45 | $303 | Direct |
| Jan 23, 2025 | ALVR Allovir, Inc. | Sale | 4 | $9.94 | $40 | Direct |
| Jan 10, 2025 | ALVR Allovir, Inc. | Sale | 332 | $0.44 | $146 | Direct |
| Nov 19, 2024 | ALVR Allovir, Inc. | Sale | 554 | $0.55 | $304 | Direct |
| Nov 5, 2024 | ALVR Allovir, Inc. | Sale | 1,655 | $0.86 | $1,431 | Direct |
1-10 of 13 transactions